Stem Cell Innovations, Inc. announced today that the Company has initiated a collaboration with the University of Twente (the Netherlands) to explore the bone forming properties of PluriCells.

Under the material transfer agreement, the University of Twente will get access to Stem Cell Innovations (SCI) proprietary human pluripotent stem cell technology and know-how. In return SCI will receive a nonexclusive license to intellectual property generated with the PluriCells.

Stem Cell Innovations recently disclosed it has produced multiple lines of human pluripotent stem cells. These PluriCell lines can be efficiently cultured in tissue culture plates without the use of feeder layers and can be efficiently differentiated into multiple cell-types, having the potential to aid in drug discovery and development.

Additional information is available at www.stemcellinnovations.com .

Contact Stem Cell Innovations:

Dr. James H. Kelly, +1 281-679-7900
or
Ivo Piest, +31 71 711 8010 (Europe)


  • Scientists Coax Pluripotent Stem Cells from Skin to Form Heart and Blood Cells
  • California Institute for Regenerative Medicine Awards $5.6 Million Grants For Stem Cell Research
  • Scientists Discover Flexible Stem Cells in Placenta
  • FDA Approves Stem Cell Trial for Chronic Ischemia
  • Human Mesenchymal Stem Cells Can Complement Duchenne Muscular Dystrophy Myotubes
  • Indian Government Focusses on Stem Cell Research; Strategy Overview
  • World's First Cultured Stem Cell Implant in Orthopaedic Patient
  • Scientists Developed Embryonic Stem Cell Substitute from Mouse Skin Cell
  • Madison opens second stem cell national bank
  • Massachusetts researchers claimed to have created pluripotent stem cells without side effect